PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Insurance Benefits”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,441 records · Page 80Linked to original sources

An unadjusted NNT was a moderately good predictor of health benefit.

BACKGROUND AND OBJECTIVE: Whether the number needed to treat (NNT) is sufficiently precise to use in clinical practice remains unclear. We compared unadjusted NNTs to quality-adjusted life years (QALYs) gained, a more comprehensive measures of health benefit. STUDY DESIGN AND SETTING: From a subset (n = 65) of a dataset of 228 cost-effectiveness analyses, we compared how well NNTs predicted clinically important QALY gains using correlation analysis, multivariable models and receiver-operator curve (ROC) analysis. RESULTS: NNT was inversely correlated with QALY gains (P < .001); this relationship was affected by quality of life and life-expectancy gains of treatment (P 15 had a sensitivity of 82% to 100%. For ruling in therapies with high QALY gains (threshold >or=0.125 to >or=0.5 QALYs), an NNT 15 to rule in and out therapies with large QALY gains may provide general guidance regarding the magnitude of health benefit.

Cost-Benefit Analysis↗

Purchaser quality measures: progressing from wants to needs.

BACKGROUND: Purchaser demands for hospital performance data are based on the fundamental nature of benefits management-the need to reconcile costs and results. The evolution from cost-based delivery of services to prospectively priced, value-based services is occurring concurrently with the adoption of quality improvement approaches. ISSUES: The "wants" for data that purchasers articulate sometimes hide the "needs" the wants were meant to satisfy. A more efficient information agenda can be developed by exploring the nature of these needs for patients, who receive the benefits, and purchasers, who pay for them. Characteristics such as sensitivity, importance, feasibility, validity, and believability for outcome measures are discussed and then used to evaluate three popular measures of quality: cesarean section (C-section), mammography screening, and coronary artery bypass graft mortality rates. CONCLUSION: By focusing on disease/treatment/outcome-specific measurement systems, information sets helping patients, providers, and purchasers to achieve the best possible quality of outcome can be efficiently developed.

Cost-Benefit Analysis↗

Evidence for the Will Rogers phenomenon in migration of employees to managed care plans.

Employees have increasing opportunities to enroll in managed care plans, and employers tend to favor these plans because of their lower costs. However, lower costs may be the result of selection of healthier patients into managed care plans. This study measured differences in health care utilization across an indemnity plan and a managed care plan, and for all employees together. We found that apparent increases in utilization in both indemnity and managed care plans disappeared when the plans were viewed together, reflecting the migration of sicker patients from indemnity plans to managed care plans.

Employer Health Costs↗

How low can you go? The impact of reduced benefits and increased cost sharing.

Amid escalating health care costs and a managed care backlash, employers are considering traditional cost control methods from the pre-managed care era. We use an actuarial model to estimate the premium-reducing effects of two such methods: increasing employee cost sharing and reducing benefits. Starting from a baseline plan with rich benefits and low cost sharing, estimated premium savings as a result of eliminating five specific benefits were about 22 percent. The same level of savings was also achieved by increasing cost sharing from a 15 dollars copayment with no deductible to 20 percent coinsurance and a 250 dollars deductible. Further increases in cost sharing produced estimated savings of up to 50 percent. We discuss possible market- and individual-level effects of the proliferation of plans with high cost sharing and low benefits.

Actuarial Analysis↗

Saving the marriage.

Explore the source record for details and available documents.

Cost-Benefit Analysis↗

HMOs, competition, and the politics of minimum benefits.

Attempts to inject "competition" into the market for health-care financing have been inextricably linked to the fate of the HMO movement. But the track record of HMOs to date offers no compelling evidence that all other types of competitors should be barred from the race, and a new Congress is likely to be more critical of optimal "second-best" solutions than were its recent predecessors. An accommodation to some constraints may be the best public protection against the "minimum benefit" politics of special interests.

Commerce↗

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.

OBJECTIVE: To develop a basic benefit package for detection and treatment of early breast cancer by evaluating the effectiveness and costs for screening mammography, primary surgery, adjuvant therapy, and follow-up care. DATA SOURCES: Published articles were retrieved through MEDLINE; additional articles were obtained through searches of their bibliographies. Cancer statistics were taken from Surveillance, Epidemiology, and End Results (SEER) Program data, population statistics were taken from US Census data, and charges from 1993 Southern California Medicare fees were used to represent costs. STUDY SELECTION: Studies were selected on the basis of their design. Preference, in decreasing order, was given to meta-analyses of randomized trials, individual randomized clinical trials, prospective cohort studies, retrospective cohort studies, and case series. DATA EXTRACTION: Studies were examined for the effect of the intervention on overall survival, disease-free survival, and health-related quality of life. We evaluated effects on survival in terms of number of lives saved at 10 years and average years of life saved. Costs were related to the benefits observed and modeled onto a hypothetical health care organization of 500,000 lives. RESULTS: Based on this analysis, we recommend a basic benefit plan for the detection and treatment of early breast cancer that would include the following: (1) screening mammography only for women aged 50 to 69 years; (2) choice of mastectomy or breast-conserving surgery with radiation therapy for all women with early breast cancer; (3) adjuvant therapy for all women at risk of recurrence; and (4) only clinical follow-up without routine testing for metastatic disease. CONCLUSIONS: By choosing which services they provide to specific groups of patients, providers can substantially reduce their expenses and still provide quality health benefits.

Adult↗